Mark Hollis discusses an issue that came up repeatedly at ISPOR’s 17th European Congress in Amsterdam – vaccine pricing. Most of the vaccine pricing discussion at ISPOR was on vaccines treating infectious diseases in some of the poorest regions of the world. Read more here. (Source: iHS, 11/12/14).
You are here: / / Will High Demand For Ebola Vaccine Mean High Prices?